Healthcare Sales & Marketing Network News: Impel NeuroPharma

Searching News Database: Impel NeuroPharma

HSMN NewsFeed - 6 Apr 2021
Mineralys Therapeutics Closes $40 Million Series A Funding
Biopharmaceuticals Cardiology Venture Capital Personnel

HSMN NewsFeed - 10 Aug 2020
Werewolf Therapeutics Appoints Business Leader, Ellen Lubman, as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 May 2020
Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams' Role Expanded To Chairman And CEO
Biopharmaceuticals Drug Delivery Neurology Personnel

HSMN NewsFeed - 29 Aug 2018
Impel NeuroPharma Annouces First Subject Dosed In Phase 1 Trial Evaluating INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia
Biopharmaceuticals Drug Delivery Neurology

HSMN NewsFeed - 22 Jun 2018
Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Treatment of Migraine
Biopharmaceuticals Drug Delivery Neurology FDA

HSMN NewsFeed - 14 Oct 2015
Impel NeuroPharma Closes First Tranche of Series B Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 2 Sep 2015
Atossa Genetics, Inc. Announces Appointment of Scott Youmans as Chief Operating Officer
Devices Diagnostics Personnel

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.